News

Altan Pharma Announces Licensing Agreement for Generic of Antifungal Agent Caspofungin

March 4, 2016

Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announced that it has signed a licensing agreement to commercialise a generic version of caspofungin. The agreement covers the territories of Germany, France, Italy, Spain, the United Kingdom, Belgium, Portugal, Poland and Latin America. Chairman and Chief Executive Officer of Altan Pharma, Guillermo Herrera stated:… View Article

Altan Pharma Announces the Launch of Linezolid 2mg/ml Solution for Infusion in Spain

March 3, 2016

Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company today announced that it has launched linezolid 2mg/ml solution for infusion for the treatment of community acquired pneumonia and nosocomial pneumonia in Spain through its Spanish subsidiary Genéricos Españoles Laboratorio, S.A.U. According to IMS, the market for Linezolid solution for infusion in Spain was roughly €23… View Article

Altan Announces Acquisition of the GES Group

June 10, 2015

Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company today announced that it has acquired a privately held group of Spanish companies, The GES Group (“GES”). The GES Group develops, manufactures and markets specialty injectable drugs. GES, headquartered in Spain, is comprised of three operating companies: GES Genéricos Españoles Laboratorio, S.A.U.; Genfarma Laboratorio, S.L. and… View Article